Similar to that in normal PBMCs, IGHJ4 was used the most frequently by AML-derived Igs, followed by IGHJ6, IGHJ5, and IGHJ3, while IGHJ1 and IGHJ2 were barely used (Figure 3D). This evidence concerns the gene CUBN and acute myeloid leukemia.